BIASED POTENT OPIOID-LIKE AGONISTS AS IMPROVED MEDICATIONS TO TREAT CHRONIC AND ACUTE PAIN AND METHODS OF USING THE SAME Read more about BIASED POTENT OPIOID-LIKE AGONISTS AS IMPROVED MEDICATIONS TO TREAT CHRONIC AND ACUTE PAIN AND METHODS OF USING THE SAME France19714936.2Filed on 2019-03-18
FLUORINATED MU-OPIOID RECEPTOR AGONISTS Read more about FLUORINATED MU-OPIOID RECEPTOR AGONISTS US Application 63/452,879Filed on 2023-03-17
Dual-Target Dopamine D3 (D3R) and -Opioid (MOR) Receptors Ligands as Potentially Safer Analgesics Read more about Dual-Target Dopamine D3 (D3R) and -Opioid (MOR) Receptors Ligands as Potentially Safer Analgesics US Application 63/488,896Filed on 2023-03-07
Dopamine D3/D2 Receptor Partial Agonists For The Treatment Of Neuropsychiatric Disorders Read more about Dopamine D3/D2 Receptor Partial Agonists For The Treatment Of Neuropsychiatric Disorders US Application 63/377,893Filed on 2022-09-30
SELECTIVE OPIOID RECEPTOR AGONISTS AND ANTAGONISTS Read more about SELECTIVE OPIOID RECEPTOR AGONISTS AND ANTAGONISTS US Application 63/393,035Filed on 2022-07-28
ANTIBODIES AGAINST FENTANYL AND FENTANYL ANALOGS Read more about ANTIBODIES AGAINST FENTANYL AND FENTANYL ANALOGS US Application 63/181,826Filed on 2021-04-29
PROTOCOL TO ENHANCE THERAPEUTIC EFFECTS OF TRANSCRANIAL MAGNETIC STIMULATION Read more about PROTOCOL TO ENHANCE THERAPEUTIC EFFECTS OF TRANSCRANIAL MAGNETIC STIMULATION US Application 63/286,229Filed on 2021-12-06
DUAL-TARGET MU OPIOID AND DOPAMINE D3 RECEPTORS LIGANDS; PREPARATION AND USE THEREOF Read more about DUAL-TARGET MU OPIOID AND DOPAMINE D3 RECEPTORS LIGANDS; PREPARATION AND USE THEREOF US Application 63/154,940Filed on 2021-03-01
THE DESIGN AND SYNTHESIS OF FENTANYL HAPTENS FOR A BIFUNCTIONAL HEROIN-FENTANYL VACCINE Read more about THE DESIGN AND SYNTHESIS OF FENTANYL HAPTENS FOR A BIFUNCTIONAL HEROIN-FENTANYL VACCINE US Application 62/960,187Filed on 2020-01-13
D3 RECEPTOR AGONIST COMPOUNDS; METHODS OF PREPARATION; INTERMEDIATES THEREOF; AND METHODS OF USE THEREOF Read more about D3 RECEPTOR AGONIST COMPOUNDS; METHODS OF PREPARATION; INTERMEDIATES THEREOF; AND METHODS OF USE THEREOF US Application 62/833,023Filed on 2019-04-12